Anticuerpo especifico anti-s100a4 con actividad antiangiogenica o un fragmento del mismo producido por un hibridoma seleccionado del grupo ecacc 10022401, ecacc 11051801, ecacc 11051802, ecacc 11051803 y ecacc 11051804; lineas celulares que lo producen; composición farmacéutica que la comprende; uso del anticuerpo para tratar enfermedad asociada con inflamación

The invention relates to antibodies against S100A4, methods for the preparation of these antibodies, pharmaceutical compositions comprising these antibodies, and therapeutic and diagnostic uses thereof.

Saved in:
Bibliographic Details
Main Authors MARTINEZ ESCOLA JOSEP MARIA, MESSEGUER PEYPOCH RAMON, ANTONIO COLL MANZANO, LOURDES TATIANA ROQUE NAVARRO, LUIS ANGEL GOMEZ CASAJUS, FRANCES MITJANS PRAT, CARMEN CALVIS CALPE, LAURA BARBERA FERRANDO, HERNANDEZ MIGUEZ JOSE LUIS, SHEILE DAKHEL PLAZA, LAURA PADILLA GARCIA, ADAN PLANA JAUME, MANUEL RIVAS CAÑAS, ROSA MA HERVAS VILLEGAS, MASA ALVAREZ MARC
Format Patent
LanguageSpanish
Published 14.02.2014
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The invention relates to antibodies against S100A4, methods for the preparation of these antibodies, pharmaceutical compositions comprising these antibodies, and therapeutic and diagnostic uses thereof.
Bibliography:Application Number: CL20120003538